How to Obtain AMA PRA Category 1 Credit™
Advances in Lung Cancer Evaluation
Preoperative Evaluation of the Lung Resection Candidate
First Step: Review Information Below to Begin Activity
This article is available for reading but no longer available to take the post-test and receive CME credit. You can visit the Home Page of the Cleveland Clinic Journal of Medicine for more Journal Articles.
Estimated Time of Completion: 15 minutes
This educational activity from the Cleveland Clinic Journal of Medicine examines predictors of postoperative lung function in patients who are candidates for lung resection and reviews preoperative and postoperative interventions that may improve outcomes.
Upon completing this activity, participants will be able to:
- Describe modern morbidity and mortality related to lung resection.
- Discuss the evidence supporting preoperative testing algorithms.
- Identify interventions in the preoperative and postoperative periods capable of improving outcomes.
This activity is directed to medical oncologists, radiation oncologists, pulmonologists, thoracic surgeons, internists, and nurses.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity Directors and Supplement Editors
Nathan Pennell, MD, PhD
Peter Mazzone, MD
Peter Mazzone, MD
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
|Peter Mazzone, MD (Activity Director)|
|Member of advisory committees:||
Boehringer Ingelheim and Oncimmune
The following faculty has indicated he has no relationship which, in the context of his contribution, could be perceived as a potential conflict of interest:
Nathan A. Pennell, MD, PhD
All other planners, CME staff, and content reviewers reported that they have no relevant financial relationships to disclose.
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for support of this activity from Pfizer Inc., Genentech, Inc., and Merck & Co., Inc.
(Article opens in new tab / window; return to this window to complete the activity).
This CME activity was produced by the Cleveland Clinic Journal of Medicine
and the Cleveland Clinic Center for Continuing Education.
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.